Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Partnering With Jooble

Advertising

The Latest Pharma Jobs, News and Events

pharmiweb.com today | 27 July 2017

Roxwood Medical Announces Agreement with Abbott for Distribution of Products in U.S.

Roxwood Medical Inc., a leading provider of advanced cardiovascular specialty catheters, today announced it has entered into an exclusive agreement with Abbott for distribution of Roxwood products in the United States.

"This partnership with Abbott's vascular business is a major milestone for Roxwood that allows far more patients to benefit from our catheter portfolio used during complex coronary procedures," said Mehrdad Farhangnia, chief executive officer, Roxwood Medical. "We have an amazing team at Roxwood, and are excited to work with Abbott to help patients suffering from advanced coronary artery disease."...

Roxwood's anchoring catheters (CenterCross® Ultra, MultiCross®) and microcatheters (MicroCross®) offer minimally invasive platforms for physicians to percutaneously treat patients with chronic blockages by facilitating guidewire access across the blockage, often times averting an invasive bypass procedure. Roxwood's anchoring and microcatheters will join Abbott's other product offerings including the XIENCE™ drug eluting stent and the OPTIS™ integrated optical coherence tomography system.

"Our XIENCE stent is unparalleled when it comes to safety in complex PCI cases," said Jim Mayberry, divisional vice president of U.S. Vascular Sales, Marketing and Operations, Abbott. "The inclusion of Roxwood products in our industry-leading portfolio allows Abbott to provide a comprehensive solution for the most difficult cases, including chronic total occlusions."

Percutaneous coronary interventions (PCI) are considered complex when patients have other chronic conditions such as diabetes or advanced kidney disease, when multiple vessels are involved, or if a vessel is severely blocked. The majority of PCIs performed today in the United States are considered complex in nature.1

show more

Latest Poll

Where are you most likely to apply for a job?

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.